Bio Solution Co

Bio Solution Co Cash Flow per Share

The Operating Cash Flow per Share of Bio Solution Co (086820.KQ) as of Oct 24, 2026 is -50.83 KRW. In the previous year, Operating Cash Flow per Share was -94.98 KRW — a change of -46.49% (higher).

Cash Flow per Share

-50.83KRW

YoY

-46.49%

Last updated:

Operating Cash Flow per Share of Bio Solution Co is 2025 -50.83 KRW. Operating Cash Flow per Share of Bio Solution Co was 2024 -94.98 KRW. It decreases by -46.49% higher compared to the previous year.

The Bio Solution Co Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
132.80 KRW
Jan 1, 2019
-329.23 KRW
Jan 1, 2020
-211.53 KRW
Jan 1, 2021
10.43 KRW
Jan 1, 2022
-158.43 KRW
Jan 1, 2023
89.74 KRW
Jan 1, 2024
-94.98 KRW
Jan 1, 2025
-50.83 KRW
The Bio Solution Co Cash Flow per Share history
YEARCash Flow per ShareYoY
-50.83KRW-46.49%
-94.98KRW-205.85%
89.74KRW-156.64%
-158.43KRW-1,619.60%
10.43KRW-104.93%
-211.53KRW-35.75%
-329.23KRW-347.92%
132.80KRW-1,133.10%
-12.85KRW-96.21%
-339.00KRW+2.74%
-329.94KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Solution Co Stock analysis

What does Bio Solution Co do? Bio Solution Co. Ltd. generates revenue through the manufacturing and distribution of cell therapy products and stem cell applied technologies. The company sells stem water, a cosmetic raw material containing human stem cells with whitening and anti-wrinkling effects, and keratinocyte medication for severe burns. Additionally, it offers chondrocyte therapy for arthritis treatment and develops human tissue models for toxicity and efficacy testing. The primary customers are cosmetic manufacturers and medical institutions seeking advanced therapeutic solutions. The firm's product portfolio includes stem water, keratinocyte medication, and chondrocyte therapy, all leveraging tissue engineering and stem cell technologies. These products target the cosmetic and medical sectors, with stem water appealing to the skincare market and keratinocyte and chondrocyte therapies serving medical applications. The company focuses on developing and commercializing cell-based solutions for both cosmetic and therapeutic uses. Bio Solution Co. Ltd. operates within the cell therapy and stem cell technology sector, providing specialized products that combine tissue engineering with stem cell applications. Its revenue streams are derived from the sale of cosmetic raw materials and medical therapeutics, with an emphasis on innovative, science-backed solutions for skin care and medical treatments. Bio Solution Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Solution Co stock

Operating Cash Flow per Share of Bio Solution Co is -50.83 KRW in 2025.

Operating Cash Flow per Share of Bio Solution Co changed from -94.98 KRW to -50.83 KRW, representing a -46.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Bio Solution Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bio Solution Co

All Key Metrics — Bio Solution Co